HealthcareServices

Convalescent Plasma Therapy Market Report 2026: Strategic Insights and Revenue Outlook

February 23, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the convalescent plasma therapy market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Convalescent Plasma Therapy Market show for the 2026–2030 period?

In recent years, the convalescent plasma therapy market size has expanded quickly. It is projected to grow from $0.06 billion in 2025 to $0.06 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.6%. The historical growth of this market can be attributed to various factors, including the urgent demand for pandemic treatment, the absence of targeted therapeutics, the availability of recovered donors, the issuance of emergency use authorizations, and the implementation of hospital-based plasma transfusions.

The convalescent plasma therapy market is projected to experience swift expansion in the upcoming years. Its valuation is anticipated to reach $0.11 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.5%. This expansion during the projection period stems from factors such as readiness for future outbreaks, progress in antibody testing, enhanced plasma storage solutions, broadening transfusion services, and ongoing research into immune therapies. Key trends expected during the forecast timeframe encompass a heightened application in treating emerging infectious diseases, a concentrated emphasis on high-titer antibody plasma, the growth of plasma collection infrastructure, refined donor screening and selection processes, and its incorporation into hospital-based critical care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

What Drivers Are Shaping The Development Of The Convalescent Plasma Therapy Market?

The escalating occurrence of infectious diseases is anticipated to fuel the expansion of the Convalescent Plasma Therapy market. Infectious diseases are defined as illnesses caused by detrimental microorganisms, such as bacteria, viruses, fungi, or parasites, which can be transmitted between individuals or through tainted surroundings. The growing incidence of infectious diseases is attributed to increased urbanization and global travel, leading to more frequent human contact and faster pathogen dissemination. Convalescent plasma therapy aids in combating these diseases by utilizing plasma obtained from patients who have recovered, which contains antibodies capable of neutralizing pathogens and conferring passive immunity to those currently infected, thereby bolstering the body’s defense mechanisms. For instance, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, it was reported in October 2024 that approximately 8.2 million people received a new tuberculosis diagnosis in 2023. This represents an increase from 7.5 million in 2022 and marks the highest number recorded since global TB surveillance commenced. Consequently, the rising prevalence of infectious diseases is a key factor propelling the growth of the Convalescent Plasma Therapy market.

What Segment Types Are Examined In The Convalescent Plasma Therapy Market?

The convalescent plasma therapy market covered in this report is segmented –

1) By Antibody type: IgM, IgG, IgA

2) By Application: Prophylaxis, Treatment

3) By End-Users: Hospitals And Clinics, Laboratories And Research institutes

Subsegments:

1) By IgM: Early-Stage Infection Plasma, Acute Phase Plasma

2) By IgG: High Titer IgG Plasma, Standard IgG Plasma

3) By IgA: Plasma Rich In IgA, Specific IgA Antibody Plasma

What Long-Term Trends Are Expected To Shape The Future Of The Convalescent Plasma Therapy Market?

Major companies in the convalescent plasma therapy market are concentrating on developing innovative solutions, such as hyperimmune globulin therapies, to improve treatment efficacy and overcome challenges associated with standard plasma therapies. Hyperimmune Globulin Therapies are treatments that utilize plasma containing a high concentration of specific antibodies, derived from individuals who have recovered from an infection, to offer targeted and potent immune support for patients. For instance, in October 2023, Kamada Ltd., an Israel-based biopharmaceutical company, announced significant progress regarding its product CYTOGAM (Cytomegalovirus Immune Globulin Intravenous [Human]), which is now commercially available in the U.S. following FDA approval for its manufacturing facility in Israel. At IDWeek 2023, new clinical data demonstrated a five-year survival benefit for high-risk CMV mismatch lung transplant patients receiving CYTOGAM. Additionally, Kamada has formed its first Scientific Advisory Board to strengthen U.S. clinical programs for the product.

Who Are The Primary Competitors In The Global Convalescent Plasma Therapy Market?

Major companies operating in the convalescent plasma therapy market are Bio Farma, Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank, Kedrion Biopharma Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Which Regions Are Projected To Dominate The Convalescent Plasma Therapy Market In The Coming Years?

North America was the largest region in the convalescent plasma therapy market in 2025. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Convalescent Plasma Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3233&type=smp

Browse Through More Reports Similar to the Global Convalescent Plasma Therapy Market 2026, By The Business Research Company

Blood Plasma Derivatives Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Therapeutic Plasma Exchange Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report

Home Infusion Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/home-infusion-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795